Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by princeofcuton Sep 09, 2015 2:09pm
83 Views
Post# 24089826

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RVX filed a Prelimiary short form prospectus

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RVX filed a Prelimiary short form prospectusROTFLMAO...why miss piggy you post just like miss piggy all huffy and puffy....so on Apr 22 he pumped ODD with a statement like we will id ODD's by Q end (and this i believe after multiple pumps of "blowing socks off" "or "straw houses over" or sum such hyperbolistic silliness...but the Q came and went with nothing provided and miss piggy the point is the Q came and went with nothing provided and so DM missed another one just like all the ones before that.. i concluded he simply didn't know all he should've known before he decided to pump (or as likely under the supposed protection of safe harbour can say just about anything) .only little piggies like you care whether he was lieing or not, i care nothing of that, the important point to me is that i simply won't take his word for any "forward looking statement" as he is to me simply unreliable (and BTW IMO a key valuation difference between RVX and say ESPR is the reliability or lack of the CEO's)
Bullboard Posts